Kayode Ogungbenro

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

CPT: pharmacometrics & systems pharmacology

British journal of clinical pharmacology

JAC-antimicrobial resistance

Clinical pharmacology and therapeutics

The University of Manchester

The University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Manchester Feb 01 2014

United Kingdom

Lecturer :: Manchester Pharmacy School

Education History

The University of Manchester Oct 01 2001 - Dec 31 2014

United Kingdom

PHD :: Manchester Pharmacy School

Publications

Jan Hansel, Fahmida Mannan, Rebecca C Robey, Mary Kumarendran, Siân Bladon, Alexander G Mathioudakis, Kayode Ogungbenro, Paul Dark, Timothy W Felton
Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis. JAC-antimicrobial resistance 6 (1) (2024)
Jan Hansel, Fahmida Mannan, Rebecca C Robey, Mary Kumarendran, Siân Bladon, Alexander G Mathioudakis, Kayode Ogungbenro, Paul Dark, Timothy W Felton
Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis. JAC-antimicrobial resistance 6 (1) (2024)
Estelle Yau, Michael Gertz, Kayode Ogungbenro, Leon Aarons, Andres M Olivares-Morales
A "middle-out approach" for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Yumi Cleary, Heidemarie Kletzl, Paul Grimsey, Katja Heinig, Kayode Ogungbenro, Hanna Elisabeth Silber Baumann, Nicolas Frey, Leon Aarons, Aleksandra Galetin, Michael Gertz
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in Children. Clinical pharmacokinetics (2023)
Estelle Yau, Michael Gertz, Kayode Ogungbenro, Leon Aarons, Andres M Olivares-Morales
A "middle-out approach" for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models. CPT: pharmacometrics & systems pharmacology (2023)
Estelle Yau, Michael Gertz, Kayode Ogungbenro, Leon Aarons, Andres M Olivares-Morales
A "middle-out approach" for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Yukiko Murata, Sibylle Neuhoff, Amin Rostami-Hodjegan, Hiroyuki Takita, Zubida M Al-Majdoub, Kayode Ogungbenro
In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition. The AAPS journal 24 (1) (2022)
Hiroyuki Takita, Daniel Scotcher, Xiaoyan Chu, Ka Lai Yee, Kayode Ogungbenro, Aleksandra Galetin
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease. Clinical pharmacology and therapeutics 112 (3) (2022)
Adam J Lucas, Kayode Ogungbenro, Shuying Yang, Leon Aarons, Chao Chen
Evaluation of area under the concentration curve adjusted by the terminal-phase as a metric to reduce the impact of variability in bioequivalence testing. British journal of clinical pharmacology (2021)
Aurélie Lombard, Hitesh Mistry, Leon Aarons, Kayode Ogungbenro
Dose individualisation in oncology using chemotherapy-induced neutropenia: Example of docetaxel in non-small cell lung cancer patients. British journal of clinical pharmacology 87 (4) (2020)
Kayode Ogungbenro, Alkesh Patel, Mark Saunders, James Clark, Robert Duncombe
An evaluation of cetuximab dosing strategies using pharmacokinetics and cost analysis. The Journal of pharmacy and pharmacology 71 (8) (2019)
Kayode Ogungbenro, Jonathan B Wagner, Susan Abdel-Rahman, J Steven Leeder, Aleksandra Galetin
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents. European journal of clinical pharmacology 75 (9) (2019)

Kayode Ogungbenro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kayode Ogungbenro